← 홈

황반변성·망막

36개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-14 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 36개
AntibodySHOTFDACuratedFDABiologicRocheApproved

ranibizumab (Lucentis, Byooviz, Cimerli)

Wet AMD, DME, RVO, myopic CNV · VEGF-A

#VEGF-A#Antibody#Approved#FDA승인#바이오모아추천+5
효능 ORR 68%임상시험 124상태 APPROVED
AntibodySHOTFDACuratedFDABiologicRegeneronApproved

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Zaltrap)

Wet AMD, DME, RVO, diabetic retinopathy · VEGF-A / VEGF-B / PIGF

#VEGF-AVEGF-BPIGF#Antibody#Approved#FDA승인#바이오모아추천+5
효능 ORR 66.4%임상시험 110상태 APPROVED
CGTAAVBHOTFDACuratedFDABiologicSpark TherapeuticsHuman RPE65 cDNAApproved

voretigene neparvovec (Luxturna, AAV2-hRPE65v2, voretigene neparvovec-rzyl)

Inherited retinal dystrophy due to confirmed biallelic RPE65 mutations · RPE65 (AAV2)

#RPE65AAV2#CGT#Approved#FDA승인#바이오모아추천+5
임상시험 7상태 APPROVED
AntibodyJanssenderuxtecan in ovarian cance…Phase 3

infliximab (Remicade, Remicade (infliximab))

Uveitis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#인기#항체+5
임상시험 62상태 ACTIVE
AntibodystaleRegeneronPhase 2

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Aflibercept IVT)

Neovascular (Wet) Age-Related Macular Degeneration · Diabetic Macular Edema

#DiabeticMacularEdema#Antibody#Phase2#항체#면역항체+3
효능 ORR 11.4%임상시험 30상태 RECRUITING
CGTBiologicFrontera TherapeuticsPhase 2

FT-003 (FT-003)

Diabetic Macular Edema · Neovascular Age-related Macular Degenera

#NeovascularAge-relatedMacularDeg#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 4상태 RECRUITING
AntibodystaleAbbVieApproved

ADA (Adalimumab, Adalimumab (ADA))

Rheumatoid Arthritis · Uveitis

#Uveitis#Antibody#Approved#항체#면역항체+3
효능 ORR 3.6%임상시험 3상태 ACTIVE
AntibodystaleRocheApproved

Bevacizumab Injection [Avastin] (Bevacizumab Injection [Avastin])

Retinal Neovascularization; Macular Edema · Retinal Neovascularization

#RetinalNeovascularization#Antibody#Approved#항체#면역항체+3
임상시험 2상태 ACTIVE
CGTBiologicstaleNanoscope Therapeutics Inc.Phase 2

Gene Therapy product:vMCO-I (Gene Therapy product:vMCO-I)

Retinitis Pigmentosa; Retinal Diseases · Retinitis Pigmentosa

#RetinitisPigmentosa#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 2상태 ACTIVE
CGTBiologicstaleJanssen Research & Development,…Phase 1

AAVCAGsCD59 (AAVCAGsCD59)

Dry Age-related Macular Degeneration · Dry Age-related Macular Degeneration

#DryAge-relatedMacularDegeneratio#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

Active bevacizumab and Active dexamethasone (Active bevacizumab and Active dexamethasone)

Non-Ischemic Central Retinal Vein Occlusion · Non-Ischemic Central Retinal Vein Occlus

#Non-IschemicCentralRetinalVeinOc#Antibody#Phase3#항체#면역항체+2
효능 ORR 16.2%임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 2

adalimumab (Humira, Adalimumab plus Methotrexate)

Uveitis · Uveitis

#Uveitis#Antibody#Phase2#항체#면역항체+2
효능 ORR 6.35%임상시험 1상태 ACTIVE
AntibodyAbbVieApproved

adalimumab (Humira, Adalimumab plus different doses of oral glucocorticosteroid)

Uveitis · Uveitis

#Uveitis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleAbbViePhase 3

adalimumab (Humira, Adalimumab+Methotrexate)

Uveitis · Uveitis

#Uveitis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRegeneronPreclinical

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Aflibercept [Eylea])

AMD · AMD

#AMD#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Bevacizumab (Avastin, Bevacizumab, Bevacizumab (Avastin), Verteporfin (Visudyne))

Neovascular Age-related Macular Degeneration · Neovascular Age-related Macular Degenera

#NeovascularAge-relatedMacularDeg#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 3

ranibizumab (Lucentis, Bevacizumab, Ranibizumab)

Retinopathy of Prematurity Both Eyes · Retinopathy of Prematurity Both Eyes

#RetinopathyofPrematurityBothEyes#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleNational Eye Institute (NEI)Phase 1

Zenapax (Daclizumab, Daclizumab (Zenapax))

Uveitis · Uveitis

#Uveitis#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

Faricimab (Faricimab)

Age-Related Macular Degeneration; Diabetic Macular Edema · Non-Proliferative Diabetic Retinopathy

#Non-ProliferativeDiabeticRetinop#Antibody#Phase3#항체#면역항체+4
효능 ORR 16.9%임상시험 1상태 ACTIVE
ADCBiologicstaleKodiak Sciences IncPhase 3

KSI-301 (KSI-301)

Wet Macular Degeneration · Wet Macular Degeneration

#WetMacularDegeneration#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 DISCONTINUED

1 / 2 페이지

← 이전다음 →